NCT06726187

Brief Summary

Rationale: Self-report measures are frequently used for research and clinical assessments of adults with autism spectrum disorder (ASD). However, there has been little research examining agreement between self-report and informant-report in this population. Reliable self-report measures are essential for conducting research with and providing high quality clinical services for adults with autism spectrum disorder. Objective: This study aims to examine the usefulness of self-report of DSM-5-TR PD traits in adults with ASD compared to informant-reports by administering the self-report screening measure of the Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

December 10, 2024

Status Verified

May 1, 2024

Enrollment Period

1.6 years

First QC Date

December 5, 2024

Last Update Submit

December 5, 2024

Conditions

Keywords

AutismPersonality disorder

Outcome Measures

Primary Outcomes (1)

  • Score SCID-5-PD

    The main study parameters are the item scores on the SCID-5-PD.

    1 day

Study Arms (2)

1

Adults with autism spectrum disorder

Other: Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).

2

The relative of the adult with autism spectrum disorder

Other: Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult males and females (age ≥ 18 years), clinically diagnosed with ASD by a psychologist or a psychiatrist, without intellectual disability, and their informants. ASD participants will be recruited from Sarr Autism Rotterdam, the Netherlands, specialized in psychodiagnostic assessment and treatment for children, adolescents, and adults with ASD. Sarr is part of Parnassia Groep, multisite mental health institute in the Netherlands.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sarr - Parnassia Groep Antes

Rotterdam, Netherlands

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic DisorderPersonality Disorders

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 10, 2024

Study Start

March 1, 2024

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

December 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations